Drug · DIN 02462117
DAPTOMYCIN FOR INJECTION
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since March 4, 2021.
- Drug Identification Number (DIN)
- 02462117
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Daptomycin J01XX09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAPTOMYCIN | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2020: NOC 24334Abbreviated New Drug Submission (ANDS)
- October 1, 2020: NOC 24344Supplement to an Abbreviated New Drug Submission (SANDS) · Updated labelling materials and change in product name
- October 1, 2020: NOC 24353Abbreviated New Drug Submission (ANDS) · Merger - buyout
Other DINs named DAPTOMYCIN FOR INJECTION
- DIN 02490463 · Marketed
- DIN 02490838 · Marketed
- DIN 02460009 · Cancelled Pre Market
- DIN 02460017 · Cancelled Pre Market
- DIN 02494590 · Cancelled Post Market
- DIN 02511738 · Cancelled Pre Market
- DIN 02526743 · Cancelled Pre Market